Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
10 May 2023 |
On P&L |
The Company releases the first quarter 2023 financial results presentation
|
Download |
|
10 May 2023 |
On P&L |
The Company releases the press release related to the first quarter 2023 financial results
|
Download |
|
25 Apr 2023 |
On business and financial situation |
ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE)
|
Download |
|
21 Feb 2023 |
About Corporate Governance |
The Company informs about the agreements adopted by the Board of Directors
|
Download |
|
21 Feb 2023 |
On business and financial situation |
The Company releases the full year 2022 financial results presentation.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
11 Jun 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 7 June 2024 and 11 June 2024 and end of the share buyback program
|
Download |
|
07 Jun 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 31 May and 6 June 2024
|
Download |
|
31 May 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 24 May and 30 May 2024
|
Download |
|
24 May 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 17 May and 23 May 2024
|
Download |
|
21 May 2024 |
Announcement of general shareholders’ meeting |
Publication of the announcement of the call to the General Shareholders’ Meeting and the documentation related thereto.
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
05 Jul 2019 |
R&D: new licenses, patents and registered trademarks |
ROVI announces completion of the Clinical Trial Program that will support the application for marketing authorization for Doria® for the treatment of schizophrenia.
|
Download |
|
02 Jul 2019 |
Liquidity contracts and specialists |
Liquidity contract: transactions conducted in the second quarter of 2019
|
Download |
|
26 Jun 2019 |
Información sobre dividendos |
The Company informs about the dividends payment
|
Download |
|
12 Jun 2019 |
Convocatorias y acuerdos de Juntas y Asambleas generales |
ROVI releases the information related to its General Shareholders Meeting
|
Download |
|
08 May 2019 |
Convocatorias y acuerdos de Juntas y Asambleas generales |
ROVI releases the information related to its 2019 General Shareholders Meeting
|
Download |
Pages
